Studies on the involvement of histamine in the hypothalamic-pituitary-adrenal axis activation induced by nerve growth factor.
Nerve growth factor (NGF) has been shown to stimulate the hypothalamic-pituitary-adrenocortical (HPA) axis. Since NGF induces the release of histamine from mast cells and in consideration of the fact that histamine is an HPA axis activator, we investigated whether NGF adrenocortical stimulation is mediated by histamine. To accomplish with it, the H1 histamine antagonist promethazine and the H2 antagonists metiamide and zolantidine were used in freely-moving cannulated rats. The increase in plasma corticosterone concentration induced by histamine administration was prevented completely by promethazine pretreatment but was unaffected by the H2 antagonists. Neither H1 nor H2 antagonists affected the adrenocortical stimulation induced by NGF administration. Moreover, since mast cells are reportedly present in the rat adrenal gland and the locally released histamine mediates the release of adrenaline which, in turn, stimulates glucocorticoid synthesis and secretion, we studied the effect of NGF on basal and ACTH-stimulated corticosterone release from in vitro isolated quartered adrenal glands and collagenase-dispersed adrenal cells. The results from these in vitro experiments have indicated that NGF modified neither spontaneous nor stimulated corticosterone release. Altogether these observations suggest that endogenous histamine is unlikely to be involved in HPA axis stimulation by NGF and reinforce the previously proposed concept of an active participation of NGF in the control of adrenocortical activity.
Scaccianoce
S
S
Department of Human Physiology and Pharmacology, University La Sapienza, Rome, Italy. scaccianoce@uniroma1.it
Lombardo
K
K
Nicolai
R
R
Affricano
D
D
Angelucci
L
L
D000311:Adrenal Glands / Q000378:metabolism; D000818:Animals; D052160:Benzothiazoles; D002404:Catheterization; D003345:Corticosterone / Q000378:metabolism; D006632:Histamine / Q000502:physiology*; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006635:Histamine H2 Antagonists / Q000494:pharmacology; D007030:Hypothalamo-Hypophyseal System / Q000502:physiology*; D008297:Male; D008785:Metiamide / Q000494:pharmacology; D051379:Mice; D020932:Nerve Growth Factor / Q000502:physiology*; D050198:Phenoxypropanolamines; D010880:Piperidines / Q000494:pharmacology; D010913:Pituitary-Adrenal System / Q000502:physiology*; D011398:Promethazine / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D013844:Thiazoles / Q000494:pharmacology
D052160:Benzothiazoles; D006634:Histamine H1 Antagonists; D006635:Histamine H2 Antagonists; D050198:Phenoxypropanolamines; D010880:Piperidines; D013844:Thiazoles; D008785:Metiamide; D006632:Histamine; D020932:Nerve Growth Factor; D011398:Promethazine; C055302:zolantidine; D003345:Corticosterone